Indications
For the control of pain associated with orthopaedic and soft tissue surgery in dogs.
Composition
- Active substance
- fentanyl
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Recuvyra
- Active substance
- fentanyl
- Group
- Veterinary medicines
- Marketing authorisation holder
- Eli Lilly and Company Limited
- Status
- Expired
- EU authorisation
- 6 Oct 2011
- Withdrawn
- 13 Oct 2016
- EMA product number
- EMEA/V/C/002239